Positive list system giving fatal blow to minor drug companies

Published: 2006-05-15 07:00:00

Updated: 2006-05-15 07:00:00

The Korea Pharmaceutical Industry Cooperation (Chairman: Park Jae-don) (KPIC) took an urgent directorate meeting on May 9 and announced strongly to oppose the government's positive list system by illustrating many problems including ever increasing payments of the patients for their medication ex...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK